Direxion FundsLeveraged EquityLABU · NYSE Arca

Direxion Daily S&P Biotech Bull 3X ETF (LABU)

Compare Leveraged & Inverse ETFs Compare with others

Price: $261.30; —11 Sept 2026
Assets: $571.2M; Total net assets
Expense ratio: 0.96%; Category 0.00%
Yield: 0.34%; Trailing distributions

1Y return: 218.1%+185.8%; Category 32.3%
3Y CAGR: 40.1%+14.8%; Category 25.3%
5Y CAGR: -27.1%-33.2%; Category 6.1%

Loading NAV history…

Direxion Daily S&P Biotech Bull 3X ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-8.9%	+46.3%	+75.6%	+63.9%	+218.1%	+40.1%	-27.1%	-10.1%	-19.6%
Leveraged Equity average	-3.1%	-7.2%	21.2%	13.2%	32.3%	25.3%	6.1%	9.5%	-5.3%
Difference	-5.8%	+53.5%	+54.4%	+50.7%	+185.8%	+14.8%	-33.2%	-19.7%	-14.3%

Holdings

Allocation as last published by the fund.

Sector allocation

Share of the equity the fund holds.

Health care99.3%
Financial services0.7%

Asset mix

Other80.1%
Stocks26.0%

ETF details

Issuer: Direxion Funds
Category: Equity · Leveraged Equity
Ticker: LABU
Exchange: NYSE Arca
Inception: 28 May 2015 (11.3 years)
Structure: Exchange Traded Fund
Expense ratio: 0.96% (category 0.00%)
Holdings turnover: 107%
Distribution yield: 0.34%
Beta, 3 years: 3.22
Total net assets: $571.2M

Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other leveraged equity ETFs

Other ETFs in the Leveraged Equity category.

Compare Leveraged & Inverse ETFs